ADI-PEG in Patients With Metastatic Melanoma
NCT00029900
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
FED
Sponsor class
Conditions
Melanoma
Neoplasm Metastasis
Interventions
DRUG:
ADI PEG
Sponsor
FDA Office of Orphan Products Development